Success Metrics

Completion Rate
0%(0/3)
Active Trials
3(38%)
Terminated
3(38%)

Phase Distribution

Ph early_phase_1
1
13%
Ph not_applicable
4
50%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution5 total trials
Early Phase 1First-in-human
1(20.0%)
N/ANon-phased studies
4(80.0%)

Highest Phase Reached

Early Phase 1

Trial Status & Enrollment

Completion Rate

0.0%

0 of 3 finished

Non-Completion Rate

100.0%

3 ended early

Currently Active

3

trials recruiting

Total Trials

8

all time

Status Distribution
Active(5)
Terminated(3)

Detailed Status

Terminated3
Not yet recruiting2
Recruiting2
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
3
Success Rate
0.0%
Most Advanced
Early Phase 1

Trials by Phase

Early Phase 11 (20.0%)
N/A4 (80.0%)

Trials by Status

not_yet_recruiting225%
recruiting225%
active_not_recruiting113%
terminated338%

Recent Activity

Clinical Trials (8)

Drug Details

Intervention Type
OTHER
Total Trials
8